EHR machine learning and genetic colocalization link osteoporosis to female Alzheimer’s risk near MS4A6A
Random-forest models trained on UCSF records (749 expert-diagnosed Alzheimer’s disease cases and 250,545 controls) identified clinical features predictive up to seven years before the recorded onset; the seven-year model’s AUROC was 0.72 using clinical features alone. Matched-cohort follow-up in external University of California health-system records found faster Alzheimer’s diagnosis after osteoporosis in women. Genetic colocalization analyses supported a female-specific shared signal between Alzheimer’s disease, low heel bone mineral density and MS4A6A expression near the MS4A gene cluster. The paper also reports shared APOE-locus support for hyperlipidemia and Alzheimer’s disease.
Technology: Random-forest models on longitudinal electronic health records, interpreted with the SPOKE biomedical knowledge network
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Matched-cohort follow-up in external University of California health-system records found faster Alzheimer’s diagnosis after osteoporosis in women.
- Still unknown: This is hypothesis-generating observational work. EHR features may reflect healthcare access, clinician behavior, coding and biological processes; the authors explicitly state that further validation across omics data types is needed. Genetic colocalization and matched cohort associations do not establish that osteoporosis causes Alzheimer’s disease or that treating osteoporosis prevents it. The prediction model is not a prospective clinical-impact evaluation, and early risk discrimination is modest with the low-prevalence outcome.
- AI role: Random-forest models ranked EHR-derived clinical features associated with future Alzheimer’s diagnosis. The team used matched models to prioritize hypotheses, then used SPOKE to connect clinical predictors to biological networks and independent health-system data plus GWAS/eQTL colocalization to examine the osteoporosis and hyperlipidemia associations. The model-generated prioritization led to follow-up of the female-specific osteoporosis signal near MS4A6A.
Evidence sources: https://www.nature.com/articles/s43587-024-00573-8.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 101 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.